• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 03, 2024 at 12:12: PM
via Moderna (MRNA.O) and partner Merck & Co (MRK.N) said on Monday their cancer vaccine in combination with blockbuster cancer therapy Keytruda improved survival and showed durable efficacy in a mid-stage study in patients with a deadly form of skin cancer.

article source
 




Top Bottom
Back
Quote